Skip to the page

Data / Form D filings / CoFlo Medical, Inc.

CoFlo Medical, Inc.: Form D filing

CoFlo Medical, Inc., a biotechnology company in San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on November 28, 2025, reports $500,000 sold of a $6 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
135 Mississippi Street, San Francisco, CA, 94107
Phone
(650) 289-8394
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2098562

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 28, 2025New notice$6,000,000$500,000$5,500,0001Nov 5, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matthew GoldmanDirector
Kripa VaranasiDirector
Simon RuferExecutive Officer, Director
Vishnu JayaprakashExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Nov 24, 2025 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CoFlo Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.